Therapeutic efficacy of sulfadoxin/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Enseno, meskan woreda, Gurage Zone, SNNPR, Ethiopia

Ethiopian Medical Journal

Volumn 44, Issue 2, 2006, Pages 133-138

  Abebe, Workeabeba ^a  

^a Department of Pediatrics ^*  (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG COMBINATION; ETHIOPIA; FEMALE; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; ETHIOPIA; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

EID: 33845771223     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Federal Democratic Republic of Ethiopia Ministry of Health /FDRE, MOH: Malaria Control Profile, Addis Ababa, March 2000.
2. Federal Democratic Republic of Ethiopia, Ministry of Health/FDRE, and MOH: Malaria Diagnosis and Treat ment Guidelines for health workers in Ethiopia, Addis Ababa, and July 1999.
3. Cowman AF. The mechanisms of drug action and resistance in malaria.In:Hayed JD, Wolf CR, editors. Molecular genetics of drug resistance, Amsterdam: Harwood Acadamic publisher; 1997, p.221-46.
4. Dorsey Get al. sulfadoxine/pyrimethamine (SP) alone or with amodaquine or artesunate for treatment of un complicated malaria: a longitudinal randomized trial: Lancet 2002; 360: 2031-8:
5. Kremsner PG, Krishna S. Antimalarial cocktails-tropcal flavours of the Month. Lancet 2002; 360: 2031-8: Ibid: 1998-0(commentary).
6. Solo Jet al. Chloproguanil-dapsone versus Sulfadoxine/Pyrimethamine(SP) for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomized clinical trial. Lancet 2002;360:1136-46.
7. Leonardo K.Basco, Albert Same-Ekobo, Vincent Foumane nj ane, Mathieu Ndounge, Theresia Motoh, Pascal Ringwald and Georges Soula. Therapeutic efficacy of sulfadoxine/pyrimethamine (SP), amodiaquine and (SP)- Amodiaquine combination against uncomplicated falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 2002; 80:538-45.
8. WHO: a practical Handbook for Anti-malarial drug therapeutic efficacy testing for the district health worker; Regional office for Africa (Harare), 1999.
9. Smithuis FM, Monti F, Grundl M, Oo Az, Kyaw TT, Phe O, et al. Plasmodium falciparum. Senstivilty in vivo to chloroquine Pyrimethamine/sulfadoxine and Mefloquine in western Myanmar Transaction of the Royal society of Tropical Medicine and Hygiene 1997; 91: 468-72.
10. Ringward p, Keudjian A, Samw Ekobo A, Basco LK, [Chemo resistance of plasmodium falciparum in the urban areas of Yaonde, Cameroon. Part 2:evaluation of the efficacy of amodaquine and sulfadoxine pyrimethamine (SP) combination in the treatment of uncomplicated plasmodium falciparum malaria in Yaounde; Cameroon Tropical medicine and International health 2000;5:620-7(In French).
11. Sarah G Staedke, Moses R Kamya, Grant Dorsey, Anne Grace Ndeezi, Edwin D Charlbois, Phillip J Rosenthal. AQ, SP and combination therapy for treatment of uncomplicated falciparum malaria Kampala, Uganda: a randomized trial. Lancet 2001;358:368-74.
12. Warsame, A. Abdilahi, O. Nur Duale, A. Nur Ismail, A.M. Hassan, A. Mohamed, and A. Warsame. Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against plasmodium falciparum infection in Somalia. Bulletin of the World Heath Organization 2002;80:704-8.
13. H.M. Gills and D.A. Warrel Bruce-Chwatt LJ. Essential malariology, third edition, London, William Heinemann Medical Books, 1993; 134-5.